Corbus Pharmaceuticals (CRBP) Competitors $16.08 -0.48 (-2.90%) (As of 11/20/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends CRBP vs. TNXP, CEMI, RLAY, ERAS, AUTL, EOLS, PLRX, CRON, CGEM, and PRTAShould you be buying Corbus Pharmaceuticals stock or one of its competitors? The main competitors of Corbus Pharmaceuticals include Tonix Pharmaceuticals (TNXP), Chembio Diagnostics (CEMI), Relay Therapeutics (RLAY), Erasca (ERAS), Autolus Therapeutics (AUTL), Evolus (EOLS), Pliant Therapeutics (PLRX), Cronos Group (CRON), Cullinan Therapeutics (CGEM), and Prothena (PRTA). These companies are all part of the "medical" sector. Corbus Pharmaceuticals vs. Tonix Pharmaceuticals Chembio Diagnostics Relay Therapeutics Erasca Autolus Therapeutics Evolus Pliant Therapeutics Cronos Group Cullinan Therapeutics Prothena Corbus Pharmaceuticals (NASDAQ:CRBP) and Tonix Pharmaceuticals (NASDAQ:TNXP) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, dividends, risk, institutional ownership, media sentiment, valuation, profitability, community ranking and analyst recommendations. Do analysts prefer CRBP or TNXP? Corbus Pharmaceuticals presently has a consensus target price of $65.86, suggesting a potential upside of 309.56%. Tonix Pharmaceuticals has a consensus target price of $53.50, suggesting a potential upside of 28,057.89%. Given Tonix Pharmaceuticals' higher possible upside, analysts clearly believe Tonix Pharmaceuticals is more favorable than Corbus Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Corbus Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 1 Strong Buy rating(s) 3.13Tonix Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is CRBP or TNXP more profitable? Corbus Pharmaceuticals has a net margin of 0.00% compared to Tonix Pharmaceuticals' net margin of -1,197.86%. Corbus Pharmaceuticals' return on equity of -42.28% beat Tonix Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Corbus PharmaceuticalsN/A -42.28% -32.92% Tonix Pharmaceuticals -1,197.86%-163.95%-118.88% Do insiders & institutionals have more ownership in CRBP or TNXP? 64.6% of Corbus Pharmaceuticals shares are held by institutional investors. Comparatively, 82.3% of Tonix Pharmaceuticals shares are held by institutional investors. 4.0% of Corbus Pharmaceuticals shares are held by company insiders. Comparatively, 0.0% of Tonix Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Does the MarketBeat Community favor CRBP or TNXP? Corbus Pharmaceuticals received 108 more outperform votes than Tonix Pharmaceuticals when rated by MarketBeat users. Likewise, 66.87% of users gave Corbus Pharmaceuticals an outperform vote while only 61.82% of users gave Tonix Pharmaceuticals an outperform vote. CompanyUnderperformOutperformCorbus PharmaceuticalsOutperform Votes44866.87% Underperform Votes22233.13% Tonix PharmaceuticalsOutperform Votes34061.82% Underperform Votes21038.18% Which has better valuation & earnings, CRBP or TNXP? Corbus Pharmaceuticals has higher earnings, but lower revenue than Tonix Pharmaceuticals. Corbus Pharmaceuticals is trading at a lower price-to-earnings ratio than Tonix Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCorbus Pharmaceuticals$880K222.56-$44.60M-$4.69-3.43Tonix Pharmaceuticals$7.77M3.36-$116.66M-$52.740.00 Does the media prefer CRBP or TNXP? In the previous week, Tonix Pharmaceuticals had 4 more articles in the media than Corbus Pharmaceuticals. MarketBeat recorded 5 mentions for Tonix Pharmaceuticals and 1 mentions for Corbus Pharmaceuticals. Corbus Pharmaceuticals' average media sentiment score of 1.75 beat Tonix Pharmaceuticals' score of 0.28 indicating that Corbus Pharmaceuticals is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Corbus Pharmaceuticals 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Tonix Pharmaceuticals 1 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has more volatility & risk, CRBP or TNXP? Corbus Pharmaceuticals has a beta of 2.56, indicating that its stock price is 156% more volatile than the S&P 500. Comparatively, Tonix Pharmaceuticals has a beta of 2.06, indicating that its stock price is 106% more volatile than the S&P 500. SummaryCorbus Pharmaceuticals beats Tonix Pharmaceuticals on 14 of the 19 factors compared between the two stocks. Ad Priority GoldJD Vance Predicts: Wall Street vs. Trump & Your MoneyTrump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback.Get your free guide NOW before it's too late. Get Corbus Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for CRBP and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CRBP vs. The Competition Export to ExcelMetricCorbus PharmaceuticalsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$201.69M$6.48B$5.06B$8.89BDividend YieldN/A8.11%4.97%4.06%P/E Ratio-3.434.8389.0213.30Price / Sales222.56372.991,207.2881.01Price / CashN/A52.2739.1736.03Price / Book1.307.876.085.74Net Income-$44.60M$153.61M$119.07M$225.93M7 Day Performance-8.38%-2.00%-1.84%-1.32%1 Month Performance-9.00%-7.47%-3.65%0.60%1 Year Performance282.86%31.80%31.62%26.23% Corbus Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CRBPCorbus Pharmaceuticals4.8781 of 5 stars$16.08-2.9%$65.86+309.6%+249.6%$201.69M$880,000.00-3.4340Positive NewsTNXPTonix Pharmaceuticals2.9676 of 5 stars$0.19+18.8%$53.50+28,057.9%-98.8%$22.33M$7.77M0.00103Analyst ForecastGap UpHigh Trading VolumeCEMIChembio DiagnosticsN/A$0.46flatN/A+0.0%$16.71M$48.34M-0.38337Analyst ForecastRLAYRelay Therapeutics3.2712 of 5 stars$4.66-2.9%$21.22+355.4%-44.5%$803.44M$25.55M0.00304Gap DownHigh Trading VolumeERASErasca2.8027 of 5 stars$2.64-5.4%$6.08+130.4%+17.3%$788.81MN/A0.00126Analyst ForecastAnalyst RevisionAUTLAutolus Therapeutics3.4682 of 5 stars$2.80-5.1%$10.15+262.5%-36.5%$784.98M$1.70M0.00330Analyst UpgradeEOLSEvolus4.0221 of 5 stars$12.63+1.9%$23.00+82.1%+28.4%$784.55M$202.09M0.00170Positive NewsPLRXPliant Therapeutics3.4847 of 5 stars$12.73-0.5%$40.57+218.7%-11.4%$778.32M$1.58M0.0090CRONCronos Group1.7856 of 5 stars$2.01-1.0%$3.00+49.3%-3.8%$776.06M$87.24M-15.46356CGEMCullinan Therapeutics1.8234 of 5 stars$12.58-4.0%$31.67+151.7%+43.6%$762.78M$18.94M0.0030Analyst RevisionPRTAProthena1.6436 of 5 stars$14.40+2.5%$61.86+329.6%-57.8%$756.01M$91.37M0.00173Analyst DowngradeAnalyst Revision Related Companies and Tools Related Companies TNXP Alternatives CEMI Alternatives RLAY Alternatives ERAS Alternatives AUTL Alternatives EOLS Alternatives PLRX Alternatives CRON Alternatives CGEM Alternatives PRTA Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:CRBP) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Corbus Pharmaceuticals Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Corbus Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CRBP Stock Alerts